Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,325 public trials 1,974 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

NCT07287917

Conditions
Breast Diseases, Breast Neoplasms, HER2-low Hormone Receptor Positive Breast Cancer, +13 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • START Los Angeles Los Angeles, California, United States
  • Skin Cancer Institute Englewood, Colorado, United States
  • Wayne State University - Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View all 17 locations
View Trial Details
Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

NCT05633654

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
View all 356 locations
View Trial Details
Recruiting

The TASTY-steering Study

NCT07258563

Conditions
Breast Diseases, Breast Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations
  • Amsterdam UMC Amsterdam, Netherlands
  • Rijnstate Ziekenhuis Arnhem, Netherlands
  • Van Weel-Bethesda Ziekenhuis Dirksland, Netherlands
  • Ziekenhuisvoorzieningen Gelderse Vallei Ede, Netherlands
View Trial Details
Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

NCT07102381

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Oncology Institute Long Beach, California, United States
  • Cancer & Blood Research Center Los Alamitos, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
View all 33 locations
View Trial Details
Recruiting

Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer

NCT07702708

Conditions
Breast Diseases, Breast Neoplasms, HR+/HER2- Breast Cancer, +4 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Fujian Provincial Hospital Fuzhou, Fujian, China
  • The Second Affiliated Hospital of Fujian Medical University Quanzhou, Fujian, China
  • Ningde First Hospital Ningde, China
View Trial Details

Related conditions